B. Riley Wealth Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

B. Riley Wealth Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,000	Closed	-$7K	–	251
2015 Q2	$7K	Hold	1,000	–	–	0.01%	802
2015 Q1	$6K	Hold	1,000	–	–	﹤0.01%	822
2014 Q4	$5K	Hold	1,000	–	–	﹤0.01%	840
2014 Q3	$4K	Hold	1,000	–	–	﹤0.01%	920
2014 Q2	$4K	Hold	1,000	–	–	﹤0.01%	955
2014 Q1	$4K	Buy	+1,000	New	+$4.76K	﹤0.01%	903

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

B. Riley Wealth Management's CPIX Position: Q3 2015 in Review

B. Riley Wealth Management sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2015, closing a stake of 1,000 shares — an estimated $7K sold.

B. Riley Wealth Management first reported a position in CPIX in Q1 2014 and held it in 6 quarters. The position peaked at $7K in Q2 2015. 48 funds tracked by Wall St. Rank hold CPIX as of Q3 2015.

B. Riley Wealth Management reported no remaining Cumberland Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
B. Riley Wealth Management sold 1,000 Cumberland Pharmaceuticals shares in Q3 2015, an estimated $7K.
B. Riley Wealth Management first reported a position in Cumberland Pharmaceuticals in Q1 2014 and held it in 6 quarters.
B. Riley Wealth Management's Cumberland Pharmaceuticals position peaked at $7K in Q2 2015.
48 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.